NORMA SOLIS: Open Payments
NPI 1427454537 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,399 in 66 payments from 9 companies in 2025. Trend: 2023 $37,850 · 2024 $39,995 · 2025 $32,399
Speaker / faculty: $21,528Consulting: $6,525Food & beverage: $2,155Travel & lodging: $2,141Education: $50
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $15,366 |
| PFIZER INC. | 6 | $5,611 |
| Janssen Biotech, Inc. | 8 | $4,777 |
| Genentech USA, Inc. | 4 | $2,950 |
| Lilly USA, LLC | 2 | $2,250 |
| Celltrion USA Inc. | 1 | $600 |
| Merck Sharp & Dohme LLC | 5 | $503 |
| Phathom Pharmaceuticals, Inc. | 4 | $304 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $38 |
Products named: SKYRIZI, VELSIPITY, RINVOQ, TREMFYA, OMVOH, STELARA, VOQUEZNA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
